Stockholder Sues Alliqua Biomedical Over Allegedly Misleading Proxy Statement
February 27, 2018 Alliqua Biomedical, Inc. and its board of directors are facing a proposed class action lawsuit alleging violations of the Securities Exchange Act of 1934.